nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—Renal failure acute—Epirubicin—stomach cancer	0.00105	0.00163	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Capecitabine—stomach cancer	0.00104	0.00162	CcSEcCtD
Dexmedetomidine—Convulsion—Fluorouracil—stomach cancer	0.00104	0.00161	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Doxorubicin—stomach cancer	0.00103	0.0016	CcSEcCtD
Dexmedetomidine—Confusional state—Irinotecan—stomach cancer	0.00103	0.0016	CcSEcCtD
Dexmedetomidine—Hepatic function abnormal—Doxorubicin—stomach cancer	0.00103	0.00159	CcSEcCtD
Dexmedetomidine—Infection—Irinotecan—stomach cancer	0.00102	0.00158	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Irinotecan—stomach cancer	0.001	0.00155	CcSEcCtD
Dexmedetomidine—Haemoglobin—Docetaxel—stomach cancer	0.001	0.00155	CcSEcCtD
Dexmedetomidine—Haemorrhage—Docetaxel—stomach cancer	0.000996	0.00154	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Epirubicin—stomach cancer	0.000995	0.00154	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Irinotecan—stomach cancer	0.00099	0.00153	CcSEcCtD
Dexmedetomidine—Confusional state—Fluorouracil—stomach cancer	0.000989	0.00153	CcSEcCtD
Dexmedetomidine—Bradycardia—Capecitabine—stomach cancer	0.000982	0.00152	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Docetaxel—stomach cancer	0.000981	0.00152	CcSEcCtD
Dexmedetomidine—Infection—Fluorouracil—stomach cancer	0.000974	0.00151	CcSEcCtD
Dexmedetomidine—Renal failure acute—Doxorubicin—stomach cancer	0.000973	0.00151	CcSEcCtD
Dexmedetomidine—Haemoglobin—Capecitabine—stomach cancer	0.000969	0.0015	CcSEcCtD
Dexmedetomidine—Haemorrhage—Capecitabine—stomach cancer	0.000964	0.00149	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Fluorouracil—stomach cancer	0.00096	0.00149	CcSEcCtD
Dexmedetomidine—Visual impairment—Docetaxel—stomach cancer	0.00096	0.00149	CcSEcCtD
Dexmedetomidine—Tachycardia—Fluorouracil—stomach cancer	0.000957	0.00148	CcSEcCtD
Dexmedetomidine—Hypotension—Irinotecan—stomach cancer	0.000957	0.00148	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Capecitabine—stomach cancer	0.00095	0.00147	CcSEcCtD
Dexmedetomidine—Visual impairment—Capecitabine—stomach cancer	0.000929	0.00144	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Docetaxel—stomach cancer	0.000924	0.00143	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Epirubicin—stomach cancer	0.000923	0.00143	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Doxorubicin—stomach cancer	0.000921	0.00143	CcSEcCtD
Dexmedetomidine—Hypotension—Fluorouracil—stomach cancer	0.000916	0.00142	CcSEcCtD
Dexmedetomidine—Dyspnoea—Irinotecan—stomach cancer	0.000913	0.00141	CcSEcCtD
Dexmedetomidine—Somnolence—Irinotecan—stomach cancer	0.00091	0.00141	CcSEcCtD
Dexmedetomidine—Angiopathy—Docetaxel—stomach cancer	0.000904	0.0014	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Docetaxel—stomach cancer	0.000898	0.00139	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Capecitabine—stomach cancer	0.000895	0.00139	CcSEcCtD
Dexmedetomidine—Chills—Docetaxel—stomach cancer	0.000894	0.00138	CcSEcCtD
Dexmedetomidine—Arrhythmia—Docetaxel—stomach cancer	0.00089	0.00138	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Epirubicin—stomach cancer	0.000884	0.00137	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000884	0.00137	CcSEcCtD
Dexmedetomidine—Pain—Irinotecan—stomach cancer	0.000875	0.00136	CcSEcCtD
Dexmedetomidine—Constipation—Irinotecan—stomach cancer	0.000875	0.00136	CcSEcCtD
Dexmedetomidine—Angiopathy—Capecitabine—stomach cancer	0.000875	0.00136	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000875	0.00135	CcSEcCtD
Dexmedetomidine—Dyspnoea—Fluorouracil—stomach cancer	0.000874	0.00135	CcSEcCtD
Dexmedetomidine—Mental disorder—Docetaxel—stomach cancer	0.000873	0.00135	CcSEcCtD
Dexmedetomidine—Somnolence—Fluorouracil—stomach cancer	0.000872	0.00135	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Capecitabine—stomach cancer	0.000869	0.00135	CcSEcCtD
Dexmedetomidine—Malnutrition—Docetaxel—stomach cancer	0.000867	0.00134	CcSEcCtD
Dexmedetomidine—Chills—Capecitabine—stomach cancer	0.000865	0.00134	CcSEcCtD
Dexmedetomidine—Arrhythmia—Capecitabine—stomach cancer	0.000862	0.00133	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000857	0.00133	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Doxorubicin—stomach cancer	0.000854	0.00132	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000846	0.00131	CcSEcCtD
Dexmedetomidine—Abdominal distension—Epirubicin—stomach cancer	0.000845	0.00131	CcSEcCtD
Dexmedetomidine—Mental disorder—Capecitabine—stomach cancer	0.000845	0.00131	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Irinotecan—stomach cancer	0.000844	0.00131	CcSEcCtD
Dexmedetomidine—Malnutrition—Capecitabine—stomach cancer	0.00084	0.0013	CcSEcCtD
Dexmedetomidine—Pain—Fluorouracil—stomach cancer	0.000838	0.0013	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000837	0.0013	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Doxorubicin—stomach cancer	0.000818	0.00127	CcSEcCtD
Dexmedetomidine—Body temperature increased—Irinotecan—stomach cancer	0.000809	0.00125	CcSEcCtD
Dexmedetomidine—Abdominal pain—Irinotecan—stomach cancer	0.000809	0.00125	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000809	0.00125	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Fluorouracil—stomach cancer	0.000808	0.00125	CcSEcCtD
Dexmedetomidine—Pneumonia—Methotrexate—stomach cancer	0.000804	0.00125	CcSEcCtD
Dexmedetomidine—Anaemia—Docetaxel—stomach cancer	0.000801	0.00124	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000793	0.00123	CcSEcCtD
Dexmedetomidine—Abdominal distension—Doxorubicin—stomach cancer	0.000782	0.00121	CcSEcCtD
Dexmedetomidine—Anaemia—Capecitabine—stomach cancer	0.000776	0.0012	CcSEcCtD
Dexmedetomidine—Body temperature increased—Fluorouracil—stomach cancer	0.000775	0.0012	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Epirubicin—stomach cancer	0.000757	0.00117	CcSEcCtD
Dexmedetomidine—Pneumonia—Epirubicin—stomach cancer	0.000753	0.00117	CcSEcCtD
Dexmedetomidine—Convulsion—Docetaxel—stomach cancer	0.000751	0.00116	CcSEcCtD
Dexmedetomidine—Hypertension—Docetaxel—stomach cancer	0.000749	0.00116	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Epirubicin—stomach cancer	0.000734	0.00114	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Epirubicin—stomach cancer	0.000727	0.00113	CcSEcCtD
Dexmedetomidine—Hypertension—Capecitabine—stomach cancer	0.000725	0.00112	CcSEcCtD
Dexmedetomidine—Dry mouth—Docetaxel—stomach cancer	0.000722	0.00112	CcSEcCtD
Dexmedetomidine—Haemoglobin—Methotrexate—stomach cancer	0.000722	0.00112	CcSEcCtD
Dexmedetomidine—Haemorrhage—Methotrexate—stomach cancer	0.000718	0.00111	CcSEcCtD
Dexmedetomidine—Confusional state—Docetaxel—stomach cancer	0.000714	0.00111	CcSEcCtD
Dexmedetomidine—Anxiety—Capecitabine—stomach cancer	0.000712	0.0011	CcSEcCtD
Dexmedetomidine—Infection—Docetaxel—stomach cancer	0.000703	0.00109	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Doxorubicin—stomach cancer	0.000701	0.00109	CcSEcCtD
Dexmedetomidine—Diarrhoea—Irinotecan—stomach cancer	0.0007	0.00109	CcSEcCtD
Dexmedetomidine—Dry mouth—Capecitabine—stomach cancer	0.000699	0.00108	CcSEcCtD
Dexmedetomidine—Pneumonia—Doxorubicin—stomach cancer	0.000697	0.00108	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Docetaxel—stomach cancer	0.000693	0.00107	CcSEcCtD
Dexmedetomidine—Visual impairment—Methotrexate—stomach cancer	0.000692	0.00107	CcSEcCtD
Dexmedetomidine—Confusional state—Capecitabine—stomach cancer	0.000691	0.00107	CcSEcCtD
Dexmedetomidine—Tachycardia—Docetaxel—stomach cancer	0.000691	0.00107	CcSEcCtD
Dexmedetomidine—Bradycardia—Epirubicin—stomach cancer	0.000684	0.00106	CcSEcCtD
Dexmedetomidine—Infection—Capecitabine—stomach cancer	0.000681	0.00105	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000679	0.00105	CcSEcCtD
Dexmedetomidine—Dizziness—Irinotecan—stomach cancer	0.000677	0.00105	CcSEcCtD
Dexmedetomidine—Haemoglobin—Epirubicin—stomach cancer	0.000675	0.00105	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Doxorubicin—stomach cancer	0.000673	0.00104	CcSEcCtD
Dexmedetomidine—Haemorrhage—Epirubicin—stomach cancer	0.000672	0.00104	CcSEcCtD
Dexmedetomidine—Diarrhoea—Fluorouracil—stomach cancer	0.000671	0.00104	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Capecitabine—stomach cancer	0.000671	0.00104	CcSEcCtD
Dexmedetomidine—Tachycardia—Capecitabine—stomach cancer	0.000669	0.00104	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Methotrexate—stomach cancer	0.000666	0.00103	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Capecitabine—stomach cancer	0.000662	0.00103	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Epirubicin—stomach cancer	0.000662	0.00103	CcSEcCtD
Dexmedetomidine—Hypotension—Docetaxel—stomach cancer	0.000661	0.00102	CcSEcCtD
Dexmedetomidine—Angiopathy—Methotrexate—stomach cancer	0.000651	0.00101	CcSEcCtD
Dexmedetomidine—Vomiting—Irinotecan—stomach cancer	0.000651	0.00101	CcSEcCtD
Dexmedetomidine—Dizziness—Fluorouracil—stomach cancer	0.000648	0.001	CcSEcCtD
Dexmedetomidine—Visual impairment—Epirubicin—stomach cancer	0.000647	0.001	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Methotrexate—stomach cancer	0.000647	0.001	CcSEcCtD
Dexmedetomidine—Rash—Irinotecan—stomach cancer	0.000645	0.001	CcSEcCtD
Dexmedetomidine—Dermatitis—Irinotecan—stomach cancer	0.000645	0.000999	CcSEcCtD
Dexmedetomidine—Chills—Methotrexate—stomach cancer	0.000644	0.000998	CcSEcCtD
Dexmedetomidine—Headache—Irinotecan—stomach cancer	0.000641	0.000994	CcSEcCtD
Dexmedetomidine—Hypotension—Capecitabine—stomach cancer	0.00064	0.000992	CcSEcCtD
Dexmedetomidine—Bradycardia—Doxorubicin—stomach cancer	0.000633	0.000981	CcSEcCtD
Dexmedetomidine—Dyspnoea—Docetaxel—stomach cancer	0.000631	0.000978	CcSEcCtD
Dexmedetomidine—Somnolence—Docetaxel—stomach cancer	0.000629	0.000975	CcSEcCtD
Dexmedetomidine—Mental disorder—Methotrexate—stomach cancer	0.000629	0.000974	CcSEcCtD
Dexmedetomidine—Malnutrition—Methotrexate—stomach cancer	0.000625	0.000968	CcSEcCtD
Dexmedetomidine—Haemoglobin—Doxorubicin—stomach cancer	0.000625	0.000968	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Epirubicin—stomach cancer	0.000624	0.000966	CcSEcCtD
Dexmedetomidine—Vomiting—Fluorouracil—stomach cancer	0.000623	0.000966	CcSEcCtD
Dexmedetomidine—Haemorrhage—Doxorubicin—stomach cancer	0.000622	0.000963	CcSEcCtD
Dexmedetomidine—Rash—Fluorouracil—stomach cancer	0.000618	0.000958	CcSEcCtD
Dexmedetomidine—Dermatitis—Fluorouracil—stomach cancer	0.000618	0.000957	CcSEcCtD
Dexmedetomidine—Headache—Fluorouracil—stomach cancer	0.000614	0.000952	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Doxorubicin—stomach cancer	0.000612	0.000949	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000611	0.000947	CcSEcCtD
Dexmedetomidine—Dyspnoea—Capecitabine—stomach cancer	0.000611	0.000946	CcSEcCtD
Dexmedetomidine—Angiopathy—Epirubicin—stomach cancer	0.00061	0.000944	CcSEcCtD
Dexmedetomidine—Nausea—Irinotecan—stomach cancer	0.000608	0.000942	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Epirubicin—stomach cancer	0.000605	0.000938	CcSEcCtD
Dexmedetomidine—Constipation—Docetaxel—stomach cancer	0.000605	0.000938	CcSEcCtD
Dexmedetomidine—Pain—Docetaxel—stomach cancer	0.000605	0.000938	CcSEcCtD
Dexmedetomidine—Chills—Epirubicin—stomach cancer	0.000603	0.000934	CcSEcCtD
Dexmedetomidine—Arrhythmia—Epirubicin—stomach cancer	0.0006	0.00093	CcSEcCtD
Dexmedetomidine—Visual impairment—Doxorubicin—stomach cancer	0.000599	0.000928	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000592	0.000916	CcSEcCtD
Dexmedetomidine—Mental disorder—Epirubicin—stomach cancer	0.000589	0.000912	CcSEcCtD
Dexmedetomidine—Pain—Capecitabine—stomach cancer	0.000586	0.000908	CcSEcCtD
Dexmedetomidine—Constipation—Capecitabine—stomach cancer	0.000586	0.000908	CcSEcCtD
Dexmedetomidine—Malnutrition—Epirubicin—stomach cancer	0.000585	0.000906	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Docetaxel—stomach cancer	0.000583	0.000904	CcSEcCtD
Dexmedetomidine—Nausea—Fluorouracil—stomach cancer	0.000582	0.000902	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000579	0.000897	CcSEcCtD
Dexmedetomidine—Anaemia—Methotrexate—stomach cancer	0.000578	0.000895	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Doxorubicin—stomach cancer	0.000577	0.000894	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Capecitabine—stomach cancer	0.000565	0.000875	CcSEcCtD
Dexmedetomidine—Angiopathy—Doxorubicin—stomach cancer	0.000564	0.000874	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Capecitabine—stomach cancer	0.00056	0.000868	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Doxorubicin—stomach cancer	0.00056	0.000868	CcSEcCtD
Dexmedetomidine—Body temperature increased—Docetaxel—stomach cancer	0.000559	0.000867	CcSEcCtD
Dexmedetomidine—Abdominal pain—Docetaxel—stomach cancer	0.000559	0.000867	CcSEcCtD
Dexmedetomidine—Chills—Doxorubicin—stomach cancer	0.000558	0.000864	CcSEcCtD
Dexmedetomidine—Arrhythmia—Doxorubicin—stomach cancer	0.000555	0.00086	CcSEcCtD
Dexmedetomidine—Mental disorder—Doxorubicin—stomach cancer	0.000545	0.000844	CcSEcCtD
Dexmedetomidine—Abdominal pain—Capecitabine—stomach cancer	0.000542	0.000839	CcSEcCtD
Dexmedetomidine—Body temperature increased—Capecitabine—stomach cancer	0.000542	0.000839	CcSEcCtD
Dexmedetomidine—Convulsion—Methotrexate—stomach cancer	0.000541	0.000839	CcSEcCtD
Dexmedetomidine—Malnutrition—Doxorubicin—stomach cancer	0.000541	0.000838	CcSEcCtD
Dexmedetomidine—Anaemia—Epirubicin—stomach cancer	0.000541	0.000838	CcSEcCtD
Dexmedetomidine—Agitation—Epirubicin—stomach cancer	0.000537	0.000833	CcSEcCtD
Dexmedetomidine—Confusional state—Methotrexate—stomach cancer	0.000514	0.000797	CcSEcCtD
Dexmedetomidine—Convulsion—Epirubicin—stomach cancer	0.000507	0.000785	CcSEcCtD
Dexmedetomidine—Infection—Methotrexate—stomach cancer	0.000507	0.000785	CcSEcCtD
Dexmedetomidine—Hypertension—Epirubicin—stomach cancer	0.000505	0.000782	CcSEcCtD
Dexmedetomidine—Anaemia—Doxorubicin—stomach cancer	0.0005	0.000775	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Methotrexate—stomach cancer	0.000499	0.000774	CcSEcCtD
Dexmedetomidine—Agitation—Doxorubicin—stomach cancer	0.000497	0.000771	CcSEcCtD
Dexmedetomidine—Anxiety—Epirubicin—stomach cancer	0.000496	0.000769	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Methotrexate—stomach cancer	0.000493	0.000764	CcSEcCtD
Dexmedetomidine—Dry mouth—Epirubicin—stomach cancer	0.000487	0.000754	CcSEcCtD
Dexmedetomidine—Diarrhoea—Docetaxel—stomach cancer	0.000484	0.00075	CcSEcCtD
Dexmedetomidine—Confusional state—Epirubicin—stomach cancer	0.000481	0.000746	CcSEcCtD
Dexmedetomidine—Hypotension—Methotrexate—stomach cancer	0.000477	0.000738	CcSEcCtD
Dexmedetomidine—Infection—Epirubicin—stomach cancer	0.000474	0.000735	CcSEcCtD
Dexmedetomidine—Convulsion—Doxorubicin—stomach cancer	0.000469	0.000726	CcSEcCtD
Dexmedetomidine—Diarrhoea—Capecitabine—stomach cancer	0.000469	0.000726	CcSEcCtD
Dexmedetomidine—Dizziness—Docetaxel—stomach cancer	0.000468	0.000725	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Epirubicin—stomach cancer	0.000467	0.000724	CcSEcCtD
Dexmedetomidine—Hypertension—Doxorubicin—stomach cancer	0.000467	0.000724	CcSEcCtD
Dexmedetomidine—Tachycardia—Epirubicin—stomach cancer	0.000466	0.000722	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Epirubicin—stomach cancer	0.000461	0.000715	CcSEcCtD
Dexmedetomidine—Anxiety—Doxorubicin—stomach cancer	0.000459	0.000711	CcSEcCtD
Dexmedetomidine—Dyspnoea—Methotrexate—stomach cancer	0.000455	0.000705	CcSEcCtD
Dexmedetomidine—Somnolence—Methotrexate—stomach cancer	0.000453	0.000703	CcSEcCtD
Dexmedetomidine—Dizziness—Capecitabine—stomach cancer	0.000453	0.000702	CcSEcCtD
Dexmedetomidine—Dry mouth—Doxorubicin—stomach cancer	0.000451	0.000698	CcSEcCtD
Dexmedetomidine—Vomiting—Docetaxel—stomach cancer	0.00045	0.000697	CcSEcCtD
Dexmedetomidine—Rash—Docetaxel—stomach cancer	0.000446	0.000691	CcSEcCtD
Dexmedetomidine—Hypotension—Epirubicin—stomach cancer	0.000446	0.000691	CcSEcCtD
Dexmedetomidine—Dermatitis—Docetaxel—stomach cancer	0.000446	0.000691	CcSEcCtD
Dexmedetomidine—Confusional state—Doxorubicin—stomach cancer	0.000445	0.00069	CcSEcCtD
Dexmedetomidine—Headache—Docetaxel—stomach cancer	0.000443	0.000687	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00044	0.000682	CcSEcCtD
Dexmedetomidine—Infection—Doxorubicin—stomach cancer	0.000439	0.00068	CcSEcCtD
Dexmedetomidine—Pain—Methotrexate—stomach cancer	0.000436	0.000676	CcSEcCtD
Dexmedetomidine—Vomiting—Capecitabine—stomach cancer	0.000436	0.000675	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000432	0.00067	CcSEcCtD
Dexmedetomidine—Rash—Capecitabine—stomach cancer	0.000432	0.000669	CcSEcCtD
Dexmedetomidine—Dermatitis—Capecitabine—stomach cancer	0.000432	0.000669	CcSEcCtD
Dexmedetomidine—Tachycardia—Doxorubicin—stomach cancer	0.000431	0.000668	CcSEcCtD
Dexmedetomidine—Headache—Capecitabine—stomach cancer	0.000429	0.000665	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000427	0.000662	CcSEcCtD
Dexmedetomidine—Dyspnoea—Epirubicin—stomach cancer	0.000426	0.000659	CcSEcCtD
Dexmedetomidine—Somnolence—Epirubicin—stomach cancer	0.000424	0.000657	CcSEcCtD
Dexmedetomidine—Nausea—Docetaxel—stomach cancer	0.00042	0.000651	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Methotrexate—stomach cancer	0.00042	0.000651	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000417	0.000646	CcSEcCtD
Dexmedetomidine—Hypotension—Doxorubicin—stomach cancer	0.000413	0.000639	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000412	0.000638	CcSEcCtD
Dexmedetomidine—Pain—Epirubicin—stomach cancer	0.000408	0.000632	CcSEcCtD
Dexmedetomidine—Constipation—Epirubicin—stomach cancer	0.000408	0.000632	CcSEcCtD
Dexmedetomidine—Nausea—Capecitabine—stomach cancer	0.000407	0.000631	CcSEcCtD
Dexmedetomidine—Body temperature increased—Methotrexate—stomach cancer	0.000403	0.000625	CcSEcCtD
Dexmedetomidine—Abdominal pain—Methotrexate—stomach cancer	0.000403	0.000625	CcSEcCtD
Dexmedetomidine—Dyspnoea—Doxorubicin—stomach cancer	0.000394	0.00061	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Epirubicin—stomach cancer	0.000393	0.000609	CcSEcCtD
Dexmedetomidine—Somnolence—Doxorubicin—stomach cancer	0.000393	0.000608	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Epirubicin—stomach cancer	0.00039	0.000605	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000381	0.000591	CcSEcCtD
Dexmedetomidine—Constipation—Doxorubicin—stomach cancer	0.000378	0.000585	CcSEcCtD
Dexmedetomidine—Pain—Doxorubicin—stomach cancer	0.000378	0.000585	CcSEcCtD
Dexmedetomidine—Abdominal pain—Epirubicin—stomach cancer	0.000377	0.000585	CcSEcCtD
Dexmedetomidine—Body temperature increased—Epirubicin—stomach cancer	0.000377	0.000585	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Doxorubicin—stomach cancer	0.000364	0.000564	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000361	0.00056	CcSEcCtD
Dexmedetomidine—Body temperature increased—Doxorubicin—stomach cancer	0.000349	0.000541	CcSEcCtD
Dexmedetomidine—Abdominal pain—Doxorubicin—stomach cancer	0.000349	0.000541	CcSEcCtD
Dexmedetomidine—Diarrhoea—Methotrexate—stomach cancer	0.000349	0.000541	CcSEcCtD
Dexmedetomidine—Dizziness—Methotrexate—stomach cancer	0.000337	0.000523	CcSEcCtD
Dexmedetomidine—Diarrhoea—Epirubicin—stomach cancer	0.000327	0.000506	CcSEcCtD
Dexmedetomidine—Vomiting—Methotrexate—stomach cancer	0.000324	0.000502	CcSEcCtD
Dexmedetomidine—Rash—Methotrexate—stomach cancer	0.000322	0.000498	CcSEcCtD
Dexmedetomidine—Dermatitis—Methotrexate—stomach cancer	0.000321	0.000498	CcSEcCtD
Dexmedetomidine—Headache—Methotrexate—stomach cancer	0.00032	0.000495	CcSEcCtD
Dexmedetomidine—Dizziness—Epirubicin—stomach cancer	0.000316	0.000489	CcSEcCtD
Dexmedetomidine—Vomiting—Epirubicin—stomach cancer	0.000303	0.00047	CcSEcCtD
Dexmedetomidine—Nausea—Methotrexate—stomach cancer	0.000303	0.000469	CcSEcCtD
Dexmedetomidine—Diarrhoea—Doxorubicin—stomach cancer	0.000302	0.000468	CcSEcCtD
Dexmedetomidine—Rash—Epirubicin—stomach cancer	0.000301	0.000466	CcSEcCtD
Dexmedetomidine—Dermatitis—Epirubicin—stomach cancer	0.000301	0.000466	CcSEcCtD
Dexmedetomidine—Headache—Epirubicin—stomach cancer	0.000299	0.000463	CcSEcCtD
Dexmedetomidine—Dizziness—Doxorubicin—stomach cancer	0.000292	0.000453	CcSEcCtD
Dexmedetomidine—Nausea—Epirubicin—stomach cancer	0.000284	0.000439	CcSEcCtD
Dexmedetomidine—Vomiting—Doxorubicin—stomach cancer	0.000281	0.000435	CcSEcCtD
Dexmedetomidine—Rash—Doxorubicin—stomach cancer	0.000278	0.000431	CcSEcCtD
Dexmedetomidine—Dermatitis—Doxorubicin—stomach cancer	0.000278	0.000431	CcSEcCtD
Dexmedetomidine—Headache—Doxorubicin—stomach cancer	0.000277	0.000429	CcSEcCtD
Dexmedetomidine—Nausea—Doxorubicin—stomach cancer	0.000262	0.000406	CcSEcCtD
Dexmedetomidine—CYP1A1—Metabolism—GSTM1—stomach cancer	3.3e-05	9.31e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IRS2—stomach cancer	3.3e-05	9.31e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ERCC2—stomach cancer	3.29e-05	9.28e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	3.28e-05	9.26e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP2A6—stomach cancer	3.27e-05	9.21e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—PIK3CA—stomach cancer	3.26e-05	9.2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PRKCB—stomach cancer	3.26e-05	9.2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	3.25e-05	9.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IRS2—stomach cancer	3.25e-05	9.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6ST—stomach cancer	3.25e-05	9.16e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CD44—stomach cancer	3.24e-05	9.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6R—stomach cancer	3.21e-05	9.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CAV1—stomach cancer	3.2e-05	9.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—APOA1—stomach cancer	3.19e-05	9e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AKR1C3—stomach cancer	3.18e-05	8.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—TP53—stomach cancer	3.16e-05	8.9e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—MAPK1—stomach cancer	3.15e-05	8.88e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CAV1—stomach cancer	3.15e-05	8.88e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—EGFR—stomach cancer	3.15e-05	8.88e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—APOA1—stomach cancer	3.14e-05	8.86e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—APC—stomach cancer	3.12e-05	8.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—FYN—stomach cancer	3.12e-05	8.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CAV1—stomach cancer	3.11e-05	8.77e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ERCC2—stomach cancer	3.1e-05	8.75e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—APOA1—stomach cancer	3.1e-05	8.75e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ENO1—stomach cancer	3.1e-05	8.73e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—MTHFR—stomach cancer	3.09e-05	8.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PRKCB—stomach cancer	3.05e-05	8.59e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.05e-05	8.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6ST—stomach cancer	3.03e-05	8.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ALB—stomach cancer	3.02e-05	8.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—HRAS—stomach cancer	3.02e-05	8.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—PIK3CA—stomach cancer	3.01e-05	8.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—SERPINE1—stomach cancer	3e-05	8.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PRKCB—stomach cancer	3e-05	8.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—MAPK3—stomach cancer	2.99e-05	8.43e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6ST—stomach cancer	2.99e-05	8.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—KRAS—stomach cancer	2.97e-05	8.39e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	2.95e-05	8.32e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	2.93e-05	8.26e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—MTHFR—stomach cancer	2.92e-05	8.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—APC—stomach cancer	2.91e-05	8.22e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RHOA—stomach cancer	2.9e-05	8.18e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6R—stomach cancer	2.9e-05	8.17e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—NOS3—stomach cancer	2.89e-05	8.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NOS3—stomach cancer	2.87e-05	8.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—APC—stomach cancer	2.87e-05	8.09e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CAV1—stomach cancer	2.85e-05	8.05e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—APOA1—stomach cancer	2.85e-05	8.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—MAPK1—stomach cancer	2.84e-05	8.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—EGFR—stomach cancer	2.84e-05	8.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—MAPK3—stomach cancer	2.79e-05	7.87e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	2.76e-05	7.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—MAPK3—stomach cancer	2.75e-05	7.75e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CD44—stomach cancer	2.75e-05	7.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—PIK3CA—stomach cancer	2.73e-05	7.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PPARG—stomach cancer	2.73e-05	7.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—PIK3CA—stomach cancer	2.72e-05	7.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SERPINE1—stomach cancer	2.71e-05	7.65e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6R—stomach cancer	2.71e-05	7.63e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GSTP1—stomach cancer	2.7e-05	7.62e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CAV1—stomach cancer	2.69e-05	7.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—KRAS—stomach cancer	2.69e-05	7.57e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOA1—stomach cancer	2.68e-05	7.57e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—ERBB2—stomach cancer	2.68e-05	7.57e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IRS2—stomach cancer	2.68e-05	7.56e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—HMOX1—stomach cancer	2.67e-05	7.52e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.66e-05	7.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6R—stomach cancer	2.66e-05	7.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—MAPK1—stomach cancer	2.66e-05	7.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—EGFR—stomach cancer	2.66e-05	7.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PTGS2—stomach cancer	2.65e-05	7.46e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RHOA—stomach cancer	2.62e-05	7.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	2.61e-05	7.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	2.61e-05	7.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	2.6e-05	7.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	2.59e-05	7.31e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NOS3—stomach cancer	2.59e-05	7.3e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.57e-05	7.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCL8—stomach cancer	2.54e-05	7.18e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—PIK3CA—stomach cancer	2.54e-05	7.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SERPINE1—stomach cancer	2.53e-05	7.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HRAS—stomach cancer	2.53e-05	7.13e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—TYMS—stomach cancer	2.51e-05	7.09e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PPARG—stomach cancer	2.51e-05	7.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—KRAS—stomach cancer	2.51e-05	7.07e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	2.5e-05	7.04e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	2.49e-05	7.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CDKN1B—stomach cancer	2.49e-05	7.01e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GSTM1—stomach cancer	2.48e-05	7.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	2.47e-05	6.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	2.47e-05	6.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	2.47e-05	6.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	2.46e-05	6.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ALB—stomach cancer	2.46e-05	6.93e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RHOA—stomach cancer	2.44e-05	6.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	2.42e-05	6.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6—stomach cancer	2.42e-05	6.82e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NOS3—stomach cancer	2.42e-05	6.82e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RHOA—stomach cancer	2.41e-05	6.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NOS3—stomach cancer	2.38e-05	6.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCND1—stomach cancer	2.37e-05	6.69e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APC—stomach cancer	2.37e-05	6.68e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—JUN—stomach cancer	2.37e-05	6.67e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPARG—stomach cancer	2.37e-05	6.67e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—NOS3—stomach cancer	2.35e-05	6.63e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ERCC2—stomach cancer	2.34e-05	6.59e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	2.34e-05	6.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—PIK3CA—stomach cancer	2.3e-05	6.5e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MMP9—stomach cancer	2.3e-05	6.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	2.3e-05	6.48e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	2.29e-05	6.47e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GSTP1—stomach cancer	2.29e-05	6.46e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	2.28e-05	6.44e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	2.27e-05	6.4e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	2.27e-05	6.39e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ERBB2—stomach cancer	2.26e-05	6.38e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—HMOX1—stomach cancer	2.26e-05	6.37e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ALB—stomach cancer	2.26e-05	6.36e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	2.24e-05	6.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	2.24e-05	6.31e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	2.23e-05	6.28e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	2.2e-05	6.2e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MTHFR—stomach cancer	2.2e-05	6.19e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6—stomach cancer	2.18e-05	6.16e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—NOS3—stomach cancer	2.16e-05	6.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	2.16e-05	6.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	2.16e-05	6.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PTGS2—stomach cancer	2.15e-05	6.06e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	2.15e-05	6.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCND1—stomach cancer	2.14e-05	6.04e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—JUN—stomach cancer	2.14e-05	6.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	2.13e-05	6.01e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—TYMS—stomach cancer	2.13e-05	6.01e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ALB—stomach cancer	2.13e-05	6e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	2.11e-05	5.96e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GSTM1—stomach cancer	2.1e-05	5.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	2.1e-05	5.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	2.1e-05	5.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MMP9—stomach cancer	2.08e-05	5.86e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	2.07e-05	5.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	2.07e-05	5.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	2.06e-05	5.82e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	2.06e-05	5.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	2.06e-05	5.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—STAT3—stomach cancer	2.05e-05	5.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6—stomach cancer	2.04e-05	5.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	2.04e-05	5.75e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—NOS3—stomach cancer	2.03e-05	5.74e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CAV1—stomach cancer	2.03e-05	5.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	2.02e-05	5.7e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOA1—stomach cancer	2.02e-05	5.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6—stomach cancer	2.01e-05	5.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCND1—stomach cancer	2e-05	5.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—JUN—stomach cancer	2e-05	5.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	1.99e-05	5.6e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ERCC2—stomach cancer	1.98e-05	5.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PTGS2—stomach cancer	1.97e-05	5.57e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCND1—stomach cancer	1.97e-05	5.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	1.97e-05	5.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—JUN—stomach cancer	1.96e-05	5.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	1.96e-05	5.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MMP9—stomach cancer	1.94e-05	5.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	1.93e-05	5.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MMP9—stomach cancer	1.91e-05	5.39e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	1.9e-05	5.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MYC—stomach cancer	1.9e-05	5.36e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	1.89e-05	5.32e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	1.87e-05	5.28e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	1.87e-05	5.26e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PTGS2—stomach cancer	1.86e-05	5.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	1.86e-05	5.25e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MTHFR—stomach cancer	1.86e-05	5.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—EGFR—stomach cancer	1.86e-05	5.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	1.86e-05	5.24e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	1.85e-05	5.21e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	1.84e-05	5.18e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARG—stomach cancer	1.78e-05	5.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	1.77e-05	4.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—KRAS—stomach cancer	1.76e-05	4.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	1.74e-05	4.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	1.74e-05	4.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	1.73e-05	4.88e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—STAT3—stomach cancer	1.73e-05	4.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MYC—stomach cancer	1.72e-05	4.84e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CAV1—stomach cancer	1.72e-05	4.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	1.72e-05	4.84e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOA1—stomach cancer	1.71e-05	4.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	1.7e-05	4.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—STAT3—stomach cancer	1.7e-05	4.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	1.68e-05	4.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	1.68e-05	4.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	1.66e-05	4.67e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	1.65e-05	4.65e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.64e-05	4.62e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PIK3CA—stomach cancer	1.63e-05	4.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	1.62e-05	4.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	1.62e-05	4.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—JUN—stomach cancer	1.62e-05	4.57e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	1.61e-05	4.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MYC—stomach cancer	1.6e-05	4.52e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ALB—stomach cancer	1.6e-05	4.52e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	1.59e-05	4.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MYC—stomach cancer	1.58e-05	4.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	1.58e-05	4.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	1.57e-05	4.43e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	1.57e-05	4.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—EGFR—stomach cancer	1.57e-05	4.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TP53—stomach cancer	1.56e-05	4.4e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	1.54e-05	4.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—EGFR—stomach cancer	1.54e-05	4.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	1.53e-05	4.32e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—NOS3—stomach cancer	1.53e-05	4.32e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARG—stomach cancer	1.51e-05	4.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HRAS—stomach cancer	1.49e-05	4.21e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—KRAS—stomach cancer	1.48e-05	4.18e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—KRAS—stomach cancer	1.46e-05	4.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	1.46e-05	4.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6—stomach cancer	1.43e-05	4.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	1.42e-05	3.99e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TP53—stomach cancer	1.41e-05	3.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	1.4e-05	3.95e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PTGS2—stomach cancer	1.4e-05	3.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	1.36e-05	3.84e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ALB—stomach cancer	1.36e-05	3.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	1.35e-05	3.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	1.34e-05	3.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	1.34e-05	3.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.32e-05	3.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TP53—stomach cancer	1.32e-05	3.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.3e-05	3.67e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NOS3—stomach cancer	1.3e-05	3.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TP53—stomach cancer	1.3e-05	3.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6—stomach cancer	1.29e-05	3.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.27e-05	3.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.27e-05	3.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HRAS—stomach cancer	1.26e-05	3.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HRAS—stomach cancer	1.24e-05	3.5e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PIK3CA—stomach cancer	1.21e-05	3.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.21e-05	3.4e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.2e-05	3.39e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PTGS2—stomach cancer	1.19e-05	3.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6—stomach cancer	1.19e-05	3.35e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PIK3CA—stomach cancer	1.14e-05	3.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.11e-05	3.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.07e-05	3.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.02e-05	2.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6—stomach cancer	9.79e-06	2.76e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PIK3CA—stomach cancer	8.62e-06	2.43e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PIK3CA—stomach cancer	7.3e-06	2.06e-05	CbGpPWpGaD
